Standout Papers

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant ple... 2011 2026 2016 2021 434
  1. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study (2011)
    Tom Treasure, Loı̈c Lang-Lazdunski et al. The Lancet Oncology

Immediate Impact

1 from Science/Nature 46 standout
Sub-graph 1 of 20

Citing Papers

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2025 Standout
Activatable Photosensitizers: From Fundamental Principles to Advanced Designs
2025 Standout
2 intermediate papers

Works of Liz Darlison being referenced

A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.
2021
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
2011 Standout

Author Peers

Author Last Decade Papers Cites
Liz Darlison 992 82 67 238 91 47 1.1k
Apostolos Nakas 925 27 102 196 8 48 1.0k
Rajesh Thomas 723 36 167 31 94 32 930
Grace Mhango 881 57 403 188 23 51 1.3k
Jo‐Åsmund Lund 855 41 240 434 87 29 1.2k
Susie L. Hu 891 62 97 181 71 32 1.2k
M. Letourneux 789 173 82 146 7 50 920
Marcus Horstmann 355 48 186 53 111 77 1.3k
A Hirsch 529 111 291 111 22 38 1.1k
Natalie L. Silver 132 54 266 171 45 70 990
Ross Mason 731 32 210 120 51 58 969

All Works

Loading papers...

Rankless by CCL
2026